Company intelligence / Profile preview

South African Nuclear Energy Corporation

Pelindaba, Gauteng, South Africa

Ownership: Private
Employees: ~1700
Development stage: Other

Overview

Necsa, through its subsidiary NTP Radioisotopes, is one of the world’s major producers of medical isotopes such as Molybdenum-99 (Mo-99), with a well-established commercial track record in global supply for diagnostic imaging and cancer treatment.[1][6]

Therapeutic areas: OncologyOther
Modalities: RadiopharmaceuticalMedical isotopeSmall molecule
Industry: Chemicals & Materials

Partnerships

US Department of Energy (NNSA)Australian Nuclear Science and Technology Organisation (ANSTO)Russia NIAEP-Atomstroyexport (Rosatom)China National Nuclear CorporationChina General Nuclear Power CorporationWestinghouseLantheus Medical Imaging

Beyond the preview

Go deeper on South African Nuclear Energy Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on South African Nuclear Energy Corporation.

Explore the full profile